Impact on Research
Finding Cures Starts Here
The Lymphoma Research Foundation is committed to funding the most promising lymphoma researchers and advancing the understanding of the more than 100 different subtypes of lymphoma. The Foundation’s disease-specificity and hyper-focus on finding cures for every type of lymphoma ensure the next generation of cancer researchers dedicate their careers to studying lymphoma, and world-leading lymphoma experts collaborate and accelerate the pace of scientific discovery.
The Foundation’s Scientific Advisory Board (SAB) is comprised of 45 world-renowned lymphoma experts, who seek out the most innovative and promising lymphoma research projects to support.
LEARN MORE
The Foundation remains dedicated to finding cures for lymphoma through an aggressively-funded program for researchers.
LEARN MORE
The Foundation’s global lymphoma consortia, research initiatives, and scientific workshops help to mobilize the research community, overcome systemic challenges and speed the progress by which new treatments are developed.
LEARN MOREInvesting in the Best and Brightest Researchers, Achieving Breakthroughs
The Lymphoma Research Foundation funds the very best science that has the greatest potential to impact patients and ensures the best and brightest researchers remain in the field.
To date, the Foundation has funded more than $80 million in lymphoma-specific research and has supported key breakthroughs including:
First In-Human Clinical Trial of Adoptive Immunotherapy in Follicular Lymphoma
First Publication of the Whole-Genome Sequencing of Mantle Cell Lymphoma
Identifying the Role RNA Splicing Plays in Chronic Lymphocytic Leukemia
Using Micro RNA Array to Identify Biomarkers that Play a Critical Role in Mantle Cell Lymphoma Drug Resistance and Progression
Identifying the Mechanism Behind Ibrutinib Resistance in Mantle Cell Lymphoma
“The Lymphoma Research Foundation had a profound impact at the beginning of my academic career, when I needed the support most. I will always be grateful to the Foundation for its continuous investment in supporting innovative science, clinical research and educational programs.” – Dr. Eduardo Sotomayor, Lymphoma Research Foundation Scientific Advisory Board Member
Meet Our 2024 Researchers
Tomohiro Aoki, MD, PhD
University Health Network
Clinical Career Development Award
Peykoff Health Equity Initiative
Preteesh Jain, MD, PhD
University of Texas MD Anderson Cancer Center
Clinical Career Development Award
Niloufer Khan, MD
City of Hope Comprehensive Cancer Center
Clinical Career Development Award, Health Equity Initiative
Christine Ryan, MD
Dana-Farber Cancer Institute
Clinical Career Development Award
Harsh Shah, DO
The University of Utah Clinical Career Development Award
Timothy Vorhees, MD
The Ohio State University College of Medicine
Clinical Career Development Award
Yucai Wang, MD
Mayo Clinic, Rochester
Clinical Career Development Award
Samuel Yamshon, MD
Weill Medical College of Cornell University
Clinical Career Development Award
Ruth Alonso-Alonso, PhD
The Trustees of Columbia University in the City of New York
Postdoctoral Fellowship Grant, Oliver W. Press MD, PhD Memorial Fellow
Gonzalo Blanco Ares, PhD
The Feinstein Institutes for Medical Research
Postdoctoral Fellowship Grant, Bruce D. Cheson MD Fellow
Alberto Carturan, MD
University of Pennsylvania Postdoctoral Fellowship Grant, Jamie Peykoff Follicular Lymphoma Fellow
Atish Kizhakeyil, PhD
University of Texas MD Anderson Cancer Center
Postdoctoral Fellowship Grant
Benedikt Pelzer, MD
Weill Medical College of Cornell University
Postdoctoral Fellowship Grant, The Levine Family Fellowship
Michael Schneider, MD, PhD
The Trustees of the University of Pennsylvania
Postdoctoral Fellowship Grant
Vignesh Shanmugam, MD
Brigham and Women’s Hospital, Inc.
Postdoctoral Fellowship Grant, Tom Condon Family Fellow
Moah Soan, DVM, PhD
Icahn School of Medicine at Mount Sinai
Postdoctoral Fellowship Grant, Jaime Peykoff Follicular Lymphoma Fellow
FINDING CURES STARTS HERE
25 Years of Innovation & Progress
1995 was a significant year for the Lymphoma Research Foundation (LRF)—it was then that the Foundation realized its dual mission to eradicate lymphoma and to serve those touched by this disease.
Finding cures starts here. Through lymphoma-specific research grants and consortia, Foundation-supported researchers have been involved in many of the most significant lymphoma breakthroughs witnessed in the past quarter-century.